Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus
Journal Title: Postępy w Kardiologii Interwencyjnej - Year 2006, Vol 2, Issue 1
Abstract
CardioSEAL/STARFlex devices (CS/SF) are double umbrella systems, which have several technical advantages such as: low profile, low nitinol content and relatively large covering surface. Our clinical experience with application of those devices is presented. Material and methods: From 1999 till 2005 transcatheter closure of undesirable shunts with CS/SF was performed in 45 patients (pts). They were divided into 3 groups: – Atrial Septal Defect (ASD): 32 pts aged 12.3 (4 to 27) years; – Persistent Foramen Ovale (PFO): 10 pts aged 31.7 (13 to 54) years; – Patent Ductus Arteriosus (PDA): 3 pts aged 16, 17 and 62 years. Indications for CS/SF implantations were: – in ASD: small, centrally located defect or multifenestrated aneurysm of the interatrial septum (IAS); – in PFO: history of cryptogenic transient ischemic attacks or stroke and right to left shunt through short PFO tunnel (
Authors and Affiliations
Jacek Białkowski, Małgorzata Szkutnik, Jacek Kusa, Paweł Banaszak, Maria Żyła-Frycz, Piotr Kapik
Zawał serca u młodego chorego z wysokim mianem przeciwciał antykardiolipinowych
The influence of coronary heart disease risk factors and alcohol abstinence on stenocardial symptoms and cardiac event recurrence after coronary stent implantation
The recurrence of stenocardial symptoms after percutaneous coronary artery stent implantation is an important limitation of the procedure. The symptoms may appear due to artery stenosis in previously dilated segment (res...
Drug eluting stents: at the crossroads?
Zabieg stentowania tętnicy szyjnej wewnętrznej u chorej z postępującym niedokrwieniem mózgu (crescendo TIA). Czy możliwa jest pierwotna angioplastyka w ostrym zespole mózgowym?
Coronary angiography and percutaneous coronary interventions in Poland between 1993 and 2004. Analysis from the perspective of the chairmen of the Working Group on Interventional Cardiology of the Polish Cardiac Society